Earnings Feed
Start Free
LEMAITRE VASCULAR INC·4

Jun 5, 5:31 PM ET

Roberts David B 4

4 · LEMAITRE VASCULAR INC · Filed Jun 5, 2026

Research Summary

AI-generated summary of this filing

Updated

LEMAITRE VASCULAR (LMAT) President David B. Roberts Receives Award

What Happened

  • David B. Roberts, President and Director of LEMAITRE VASCULAR, was credited with a total of 21.371 dividend-equivalent rights (derivative awards) on 2026-06-04. The Form 4 shows nine separate accruals (see list below). Each item was reported as an award/acquisition (code A) at a $0.00 per-share price, so no cash was paid and the reported value is $0 on the Form 4. These are not open-market purchases or sales; they are dividend equivalents that vest with underlying restricted stock units (RSUs) or performance share units (PSUs).

Key Details

  • Transaction date: 2026-06-04; Form filed: 2026-06-05 (appears timely).
  • Items credited (share equivalents and footnote references):
    • 1.824 (F1), 1.824 (F2), 3.117 (F3), 3.734 (F4), 2.708 (F5), 3.068 (F6), 0.262 (F7), 0.297 (F8), 4.537 (F9) — total 21.371.
  • Price reported: $0.00 per unit; reported total value on form: $0 (these are dividend-equivalent rights, not cash purchases).
  • Nature of instrument: derivative dividend-equivalent rights that are the economic equivalent of one share and vest proportionately with the underlying RSU/PSU awards.
  • Shares owned after the transaction: not specified in the provided extract — see the full Form 4 for total holdings and ownership percentage.
  • No 10b5-1, tax-withholding, or late-filing flags noted in the provided summary.

Context

  • Dividend-equivalent rights are credits tied to existing RSU/PSU awards; they accrue like dividends and convert to shares (or cash) only as the underlying awards vest. They are compensation-related and do not indicate an open-market buy or sell by the insider.
  • For retail investors: awards and dividend equivalents are routine executive compensation. They are informative about compensation accrual but do not necessarily signal insider sentiment about the stock.

Insider Transaction Report

Form 4
Period: 2026-06-04
LEMAITRE VASCULAR INCLMAT
Roberts David B
DirectorPresident and Director
Transactions
  • Award

    Dividend Equivalent Rights

    [F1]
    2026-06-04+1.824→ 23.342 total
    → Common Stock (1.824 underlying)
  • Award

    Dividend Equivalent Rights

    [F2]
    2026-06-04+1.824→ 22.659 total
    → Common Stock (1.824 underlying)
  • Award

    Dividend Equivalent Rights

    [F3]
    2026-06-04+3.117→ 26.708 total
    → Common Stock (3.117 underlying)
  • Award

    Dividend Equivalent Rights

    [F4]
    2026-06-04+3.734→ 28.029 total
    → Common Stock (3.734 underlying)
  • Award

    Dividend Equivalent Rights

    [F5]
    2026-06-04+2.708→ 14.384 total
    → Common Stock (2.708 underlying)
  • Award

    Dividend Equivalent Rights

    [F6]
    2026-06-04+3.068→ 15.048 total
    → Common Stock (3.068 underlying)
  • Award

    Dividend Equivalent Rights

    [F7]
    2026-06-04+0.262→ 1.681 total
    → Common Stock (0.262 underlying)
  • Award

    Dividend Equivalent Rights

    [F8]
    2026-06-04+0.297→ 1.744 total
    → Common Stock (0.297 underlying)
  • Award

    Dividend Equivalent Rights

    [F9]
    2026-06-04+4.537→ 8.375 total
    → Common Stock (4.537 underlying)
Footnotes (9)
  • [F1]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F2]These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F3]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F4]These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F5]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F6]These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F7]These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F8]These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F9]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-06-05

Documents

1 file
  • 4
    ownership.xmlPrimary

    4